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ABSTRACT When blood contacts foreign material surfaces, platelets usually adhere and form aggregates on those
surfaces, generating mural thrombi. The mechanism of mural thrombogenesis is not completely understood, but one
hypothesis states that the local release of certain platelet-active substances from the platelets composing an initial small
thrombus stimulates additional platelet recruitment to that thrombus, resulting in growth of the cell aggregate. The
purpose of this paper is to investigate the feasibility of this hypothesis. Concentration profiles of adenosine diphosphate
(ADP), thromboxane A2 (TxA2), and thrombin were computed in the vicinity of growing model thrombi 10 and 20 ,um
long. Wall shear rates of 100, 500, and 1,500 s-' were considered for blood flowing through a thin rectangular slit 200
,um wide coated with collagen, a predominant subendothelial protein. The local concentrations of ADP and TxA2 were
marginally large enough to stimulate platelet activation individually, while local thrombin levels can be much greater
than required for stimulation. Antithrombin III, a natural thrombin inhibitor, did not significantly reduce the thrombin
concentrations, but antithrombin III accelerated by heparin greatly reduced the local thrombin concentrations. The
reduced thrombin levels may, however, still be large enough to activate platelets.
INTRODUCTION
When blood contacts a foreign surface, be it the subendo-
thelium of an injured blood vessel (1), an atheromatous
plaque in a blood vessel, or an artificial polymeric surface
in a prosthetic blood-contacting device (2), blood platelets
adhere to and aggregate on that surface. The result of this
process, certainly in the case of exposed subendothelium
and atheromatous plaque and often in the case of artificial
biomaterials, is the formation of mural thrombi, discrete
aggregates of platelets at the blood-surface interface.
The formation of these thrombi is beneficial in the case
of an injured vessel, for they form a hemostatic plug and
arrest bleeding. In the case of an atheromatous plaque or
an artificial biomaterial in a blood-contacting device,
however, the formation of these thrombi is very detri-
mental, for they can embolize from the surface and flow
downstream to lodge in the circulation of vital organs. This
can cause the cessation of blood flow to parts of an organ,
resulting in local ischemia. In the most catastrophic of
cases, the result is coronary occlusion or stroke.
It is therefore desirable to understand the mechanism of
mural thrombogenesis, to perhaps develop an antithrom-
botic pharmacological treatment or design an artificial
organ so as to minimize thrombosis and subsequent embol-
ization. It has been shown that thrombi formed from
flowing blood on collagen are elongated parallel to the
direction of flow and seem to grow predominantly by
addition to the downstream end of the thrombus (3, 4).
One proposed mechanism for thrombogenesis is that the
adherent platelets, if sufficiently activated by the surface,
produce local high concentrations of platelet-active sub-
stances, which then activate other platelets flowing nearby
(3). These platelets then aggregate with the already adher-
ent platelets, forming a mural thrombus.
Probably the most important of these platelet active
substances are adenosine diphosphate (ADP), which is
released from the dense granules of the platelet, and
thromboxane A2 (TxA2) and thrombin, which are enzy-
matically generated on or near the membrane of the
platelet.
ADP is a strong stimulant of platelet activity, causing
shape change and reversible aggregation at concentrations
from 0.2 to 1.0 ,uM and irreversible aggregation at concen-
trations greater than 1.0 ,uM (5).
Thromboxane A2, an arachidonic acid metabolite, is one
of the most potent stimulators of platelet activity yet
described. TxA2 is unstable in aqueous media and under-
goes rapid nonenzymatic hydrolysis to thromboxane B2, a
biologically inactive substance. The half-life of TxA2 in
aqueous solution is 43 s (6). Because of this short half-life,
it is difficult to determine what concentrations of TxA2 are
required to stimulate activity. One of the closest TxA2
analogues, U-46619 (11,9-epoxy-methano analogue of
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PGH2, Upjohn Company), causes shape change at concen-
trations of 6 - 60 nM, reversible aggregation at 110 - 300
nM, and irreversible aggregation at concentrations greater
than 600 nM (7). It is reasonable to expect TxA2 to have
similar biological activity.
Thrombin, a serine protease, plays an important role in
the coagulation cascade, activating many of the coagula-
tion factors and converting fibrinogen to fibrin. Thrombin
also activates platelets independently of fibrin, causing
irreversible aggregation at levels of 0.1 to 0.3 units/ml (5).
Thrombin is generated enzymatically on the surface of the
platelet, where factor Va, factor Xa, and Ca 2+ combine
with platelet phospholipid to form the prothrombinase
complex, which converts plasma prothrombin to thrombin.
Thrombin may also be generated in the bulk fluid indepen-
dently of platelets, but the conversion rate is several orders
of magnitude greater in the presence of platelet membrane
(8).
Thrombin activity is inhibited by the circulating protein
antithrombin III (AT III), present in the blood at a
concentration of 4 ,uM (9). The inhibitory activity of AT
III is greatly accelerated by heparin, a commonly used
anticoagulant and antithrombotic agent. Antithrombin III
and heparin do not greatly affect the generation of throm-
bin, they mainly inactivate it after generation.
The purpose of this paper is to investigate the feasibility
of the mechanism for local control of mural thrombogene-
sis proposed above by solving the equations describing the
transport of mass from an idealized thrombus to flowing
blood in contact with the thrombus. This allows the
estimation of the concentrations that develop in the neigh-
borhood of an individual thrombus releasing and generat-
ing these platelet active species.
Similar modeling (10, 11, 12) has been performed for
the macroscopic problem, where the generation and release
of ADP, TxA2, and thrombin from platelets accumulating
on a collagen-coated surface was seen to persist near the
surface in concentrations that could affect platelet function
further downstream. This analysis gives little insight,
however, into the microscopic problem, which is to consider
if the concentrations developing near a particular throm-
bus could actually affect further aggregation at that same
thrombus. The microscopic problem has been previously
studied (13), but only in a qualitative sense, to determine
the approximate shapes of the concentration contours
generated.
FORMULATION OF THE PROBLEM
Consider a fluid flowing in fully developed laminar flow
between two parallel plates forming the walls of a thin
rectangular channel of width 2B. The fluid enters the
channel at z = -Xo with a uniform and zero concentration,
CA, of the species of interest, A. At z = 0 the fluid
encounters a mass-transfer region, extending from z = 0 to
z = L, where the species of interest is released from the wall
at a specified flux, NA, which has dimensions of moles ofA
per unit area per unit time. The fluid then proceeds
downstream, where no additional mass is released from the
wall. Furthermore, consider the possible removal of the
active diffusing substance by a first-order bulk phase
reaction, A - D, where D is some inactive form of A. The
physical situation is depicted in Fig. 1.
The diffusion convection equation describing this situa-
tion is given by
v.(x) d = DAW + aO2] - k CA,
Cx2
(1)
where DAW is the translational diffusion coefficient of A in
the fluid, k is a first-order reaction rate constant, and v,(x)
is the velocity profile which, for a Newtonian fluid, is given
by
(2)v,-[X) ]= Vmax [ -
The boundary conditions for Eq. 1 are given by
CA(X, -W) = 0
aCA (0, z) = 0
ax
-DAWCA (B, z) = N0 Z z --- LAWOx (0, z<O,z>L.
(3)
(4)
(5)
The left hand side of Eq. 1 represents mass transport in
the axial direction by convection. The right hand side of
Eq. 1 contains the diffusion and bulk phase reaction terms.
The second derivative with respect to x represents mass
transport perpendicular to the surface (across streamlines)
by diffusion. The second derivative with respect to z
represents mass transport in the axial direction by diffu-
sion. For most situations, this term has a near zero
contribution to the solution, meaning that mass transport
in the axial direction is greatly dominated by convection,
rather than by diffusion. However, the region of interest in
this study is very near the wall, where local fluid velocities
are low, even though the average velocity may be high. In
this region, the axial diffusion term must be included.
N
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FIGURE 1 Illustration of the mass transfer model, where blood flows by
a zone of length L releasing species A at a known flux N. Species A may
then be inactivated by a first order reaction in the bulk.
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Eq. I may be rendered dimensionless by introducing the
following variables:
x z CADAW
BPe' X NB
g = L Pe = VmaxB
BPe' DAW '
kBPe
K -
Vmax
This yields
ax [2X 1X 1(6)
a¢ I _ n2 adn2 + p2 d2-K] 6
where x is the dimensionless concentration of species A, r is
the dimensionless axial position from the beginning of the
flux zone, and q is the dimensionless distance from the
center of the flow channel. The boundary conditions for
Eq. 6 are
x(1, - ) = 0 (7)
49X(°.0 0(8)
,ax [1, OS %.0.(110( ' )l (9)
The parameter t0 is the dimensionless length of the flux
zone, which represents the growing thrombus. The param-
eter Pe is the Peclet number and represents the ratio of
mass transport by convection to mass transport by diffu-
sion. The parameter K iS the dimensionless reaction rate
constant.
SOLUTION OF THE PROBLEM
This elliptic differential equation, neglecting for the
moment the chemical reaction term, is known as the
extended Graetz problem with Neumann boundary condi-
tions. It has been solved analytically (14) by decomposing
Eq. 8 into two first-order partial differential equations.
The result is a series solution of expansion coefficients
multiplied by eigenfunctions, with the eigenvalues and
eigenfunctions expressed in terms of confluent hypergeom-
etric functions.
In the region of interest in this problem the dimension-
less axial positions (r) are quite small, typically from i0-4
to 10 -6. Series solutions of this type are difficult to
evaluate for small A, as they require the evaluation of many
eigenvalues and expansion coefficients. For this reason, it
was not possible to utilize this analytical solution in these
computations.
Another analytical solution exists, this one derived by
applying a double-sided Laplace transform (15). Evalua-
tion of this solution in the region of interest is, however,
also not feasible.
Because of the above difficulties, the use of an analytical
solution was abandoned and Eq. 6 was solved numerically
by collocation using bicubic Hermite elements as the basis
functions. The ELLPACK routines (16) were used to
perform the computations. A rectangular grid with non-
uniform grid spacing was used, with 52 grid lines in the r
direction and 10 in the tq direction.
Computationally, the inlet condition at negative infinity
was replaced by the same condition two thrombus lengths
upstream of t = 0. Numerical solutions for elliptic partial
differential equations require a boundary condition on all
sides of the problem. For the downstream condition, it was
assumed that the axial variation of the concentration was
small five thrombus lengths downstream of t = 0. Addi-
tionally, since the concentration profiles develop only near
the wall of the flow chamber, the symmetry condition at
the center of the flow chamber was not used. This condition
was replaced by assuming that the concentration of species
A fell to zero some distance away from the wall. This
distance was determined by performing the computations
on the simpler parabolic problem that is obtained when the
axial diffusion term is neglected. This distance ranged
from i1 = 0.8 to ? = 0.95, depending on the substance and
the wall shear rate. Additional details regarding the
numerical method have been published elsewhere (17).
Computations were performed for typical thrombi 10
and 20 gm long in a channel 200 ,tm wide. The various
parameters used in the computations for these two model
thrombi are shown in Table I. The data for the sizes and
growth rates of the thrombi were derived from experimen-
tal measurements taken in our laboratory (18).
The growth rates of individual thrombi on collagen-
coated glass in contact with flowing whole blood were
measured using epi-fluorescence video microscopy with
digital image processing. The growth rates and thrombus
sizes in Table I are typical for thrombosis on this substrate.
Collagen is a major component in the subendothelial tissue
of a blood vessel and serves as a subendothelial model.
Thrombosis on vascular subendothelium, as described, for
example, in reference one, is very similar to that on
collagen-coated glass.
Thrombus growth rates have been seen to depend upon
the local wall shear rate (1, 18). This effect is due to the
depletion of platelets in the fluid layer near the reactive
TABLE I
PARAMETERS FOR MODEL THROMBI
Thrombus Thrombus Growth . Fluxof Flux of Fluxof
length width rate ADPI* TxA'9 thrombin'
gm ,um Pit/st Plt mci/Mm2 s moi/Mm2 S units/Mm2 5S
10 10 0.2 20 4.5 10-20 2.3- 10-21 1.5.- 10`'
20 20 0.8 320 4.5- 10-20 9.1 . 10-2' 6.2. 10-10
*The superscripts indicate the original references containing the data
from which the fluxes were calculated. A description of the flux computa-
tions may be found in Appendix I.
tPlt = Platelets.
'Specific activity 3 units/,ug.
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surface as the blood flows over the surface. Transport of
platelets into the depleted zone depends on the effective
platelet diffusivity, which has been shown to be shear rate
dependent. This paper considers only small injury sites,
that is, the single mural thrombus. Such conditions are
likely to be more reasonable under physiological condi-
tions, where large regions of subendothelium are rarely
exposed. In the case of a small reactive site, rather than a
large one, there is little platelet depeletion, and the throm-
bus growth rate is not a strong function of wall shear rate.
Three platelet-activating substances were considered,
namely, ADP, TxA2, and thrombin. The flux rates were
computed from data given in references 11, 19, and 20 for
ADP, TxA2, and thrombin release and generation by
platelets stimulated by collagen. The details of the compu-
tations of the fluxes of these three species are contained in
Appendix I.
ADP was assumed to be released by the dense granules
of each platelet instantaneously as it attached to the
growing thrombus, and therefore the flux depended on the
growth rate of the thromus, rather than the size of the
thrombus. 75% of the granules were assumed to be
released. Values in this range are typical for stimulation by
collagen.
Thromboxane A2 is generated enzymatically within the
platelet, and therefore the flux depended on the number of
platelets in the mural thrombus, rather than the growth
rate. Intracellular arachidonic acid, the precursor for TxA2
production, was assumed not to be depleted. Furthermore,
diffusion of TxA2 produced by the platelets at the bottom
of a thrombus through the thrombus before release into the
flow stream was not considered. Each platelet was assumed
to have equal access to the flow stream. Thus, these
generation rates represent an upper bound on the TxA2
flux.
Thrombin is generated enzymatically on the surface of
the platelet, so thrombin flux also depends on the number
of platelets composing the thrombus. As was the case for
TxA2, each platelet was assumed to have equal access to
the flow stream, so diffusion of prothrombin (reactant) and
thrombin (product) through the thrombus was not consid-
ered. These assumptions are, therefore, approximations
that reflect the limiting case of maximum generation and
release of these three platelet-activating substances.
Three bulk phase chemical reactions were considered,
namely, the degradation of TxA2 to TxB2, the inactivation
of thrombin by AT III, and the inactivation of thrombin by
AT III accelerated by heparin. The important physical
parameters for these species and reactions are shown in
Table II.
The diffusion coefficients for ADP and TxA2 in plasma
were estimated by the Wilke-Chang correlation (21). This
method requires the knowledge of the molar volume of the
solute at its normal boiling point. The group contribution
correlation of Le Bas (22) was used to estimate these
values. The diffusion coefficient for thrombin in plasma
TABLE II
PARAMETERS FOR PLATELET ACTIVE SPECIES AND
CHEMICAL REACTIONS
Species ADP TxA2 Thrombin AT III Heparin
MW 424.2 352.5 36600 62000 20000
DAw(Cm2/S)* 2.37. 10-6 2.14. 10-6 4.16O10-7
k(s-')t 0.0161 - 0.02831 267'
*All of the diffusion coefficients were estimated by correlations in
references 21, 22, and 23. The text contains a description of the estimation
methods.
tThe pseudo first order reaction rate constants were calculated from data
in references 6, 24, and 25 for TxA2, AT III, and AT III with heparin,
respectively. A description of the computation of these values is given in
Appendix II.
For the nonenzymatic hydrolysis of TxA2 to TxB2.
IFor the inhibition of thrombin by 4 gM AT III alone.
'For the inhibition of thrombin by 4 ,M AT III accelerated by equimolar
heparin.
was estimated using a correlation developed for proteins
(23). A plasma viscosity of 1.8 centipoise was used in all of
these computations.
The reaction rate coefficients were obtained from refer-
ences 6, 24, and 25 for the degradation of TxA2 to TxB2,
the inactivation of thrombin by AT III, and the inactiva-
tion of thrombin by AT III accelerated by equimolar
heparin, respectively.
The assumption was made that the concentration of AT
III was large compared with the concentration of thrombin
in the neighborhood of a thrombus. Hence, it was not
necessary to consider the diffusion of AT III and heparin.
Similarly, the assumption was made that the plasma level
of prothrombin, the precursor of thrombin, was large
compared with the concentration of thrombin developed.
Hence, the diffusion of prothrombin to the thrombus
before conversion to thrombin was not considered. Justifi-
cations for these assumptions are given in the Results
section of this paper.
Computations were performed for three wall shear rates,
100, 500, and 1,500 s -. The lowest value corresponds to a
venous shear rate, and the highest value to an arterial shear
rate (1).
RESULTS AND DISCUSSION
Important to understanding the effect of the released and
generated platelet active substances is a knowledge of the
time that a platelet flowing nearby is exposed to these
concentrations. The time that a platelet spends directly
over the thrombus may be estimated from the parabolic
velocity profile. These times are, as one would expect,
rather short. For example, a platelet flowing 2 ,um from the
surface spends approximately 50, 10, and 3.0 ms directly
over the 10-,um thrombus for wall shear rates of 100, 500,
and 1,500s '.
Computations were performed for thrombi 10 and 20
,um long. Results for the former case are given explicitly in
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Figs. 2 to 5, and results for the latter thrombus are referred
to by comparison with the IO-,um case. The detailed results
for the 20-,um-long thrombus may be found elsewhere (12,
17).
Adenosine Diphosphate
The ADP concentration profiles developing in the neigh-
borhood of the 10 ,gm model thrombus are shown in Fig. 2.
The magnitudes of the concentrations that are attained
close to the wall are approximately 0.7 ,uM or less; recall
that 0.2 ,M ADP is required to cause shape change and
reversible aggregation in platelet rich plasma. An increase
in the wall shear rate from 100 to 1,500 s -I causes a 2.5
fold-drop in the maximal ADP concentrations. An increase
in the size of the thrombus from 10 to 20 ,m causes a slight
increase in the magnitudes of the concentrations that
develop. The reason for this relatively small increase is that
the flux of ADP from the surface depends on the rate of
granule release from the platelets, which in turn depends
on the rate of arrival of platelets to the thrombus. The rate
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FIGURE 2 Local concentration profiles for adenosine diphosphate
(ADP) released from the granules of the platelets in a 1 0-,m thrombus.
Wall-shear rates are (a) 100 s', (b) 500 s-', and (c) 1,500 s '. The
distance from the wall, where the thrombus forms, is varied parametrical-
ly, with the top number referring to the top curve, the second referring to
the second, and so on.
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FIGURE 3 Local concentration profiles for thromboxane A2 produced
by the platelets of a 10-im thrombus. Wall shear rates are (a) 100 s1,
(b) 500 s -', and (c) 1,500 s-'.
of arrival per unit area is the same for both the large and
the small thrombi.
Considering the concentrations computed in the vicinity
of the model thrombi, granule released ADP may play
some role in the modulation of thrombus growth. It is
unlikely, however, that released ADP plays a profound
role, since it appears in concentrations not greatly above
the threshold for minimal stimulation.
Thromboxane A2
The TxA2 concentration profiles computed in the vicinity
of the 10 ,m-long model thrombus are shown in Fig. 3. The
concentrations that develop are 40 nM or less. It is difficult
to quantify the biological activity of TxA2, since it has not
yet been successfully purified. For the TxA2 mimic, U-
46619, however, concentrations of 6 - 60 nM and 110 -
300 nM are required to stimulate shape change and
reversible aggregation in platelet-rich plasma. An increase
in the wall shear rate from 100 to 1,500 s-' results in a 2.5
fold drop in the maximal TxA2 concentrations. Increasing
the size of the thrombus from 10 to 20 ,um results in a
5-fold increase in the maximal concentrations. This large
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FIGURE 4 Local concentration profiles for thrombin produced by the
platelets of a 10-,um thrombus. Wall shear rates are (a) 100 s ', (b) 500
s ',and (c) 1,500 s
increase results because the TxA2 flux at the surface
depends not on the rate of platelet arrival to the thrombus,
as is the case for ADP, but on the number of platelets that
are already present in the thrombus.
It may be that TxA2 plays an important role in mural
thrombus formation at the later stages, when the thrombus
is already fairly large. TxA2 generation would appear,
however, to play only a marginally important role in the
initial stages of thrombus formation, when the cell aggre-
gate is small.
The fluid phase nonenzymatic hydrolysis of TxA2 to the
biologically inactive TxB2 was considered and was found to
have no effect on the TxA2 concentrations in the vicinity of
the thrombus. This is because its half-life, 43 s, is long
when compared with the time that a fluid element spends
in the neighborhood of a thrombus.
Thrombin
The thrombin concentration profiles computed in the
vicinity of the 10-,um-long model thrombus are shown in
Fig. 4. The concentrations that develop near the wall are
_9 units/ml. The thrombin level required to stimulate
platelet activity in platelet rich plasma is much smaller
than this value, -0.1 units/ml. Increasing the wall shear
rate from 100 to 1,500 s-1 causes an approximately
2.5-fold decrease in the maximal concentrations. Increas-
ing the size of the thrombus from 10 to 20 ,um results in a
fivefold increase in the thrombin concentrations. This large
increase is again because the thrombin flux at the wall
depends on the number of platelets that form the throm-
bus, rather than the rate of arrival of platelets to the
thrombus.
It is clear that thrombin generation is likely to play a
very important role in the mechanism of mural thrombo-
genesis. The thrombin concentrations are significantly
larger than the minimum required for both the small and
the large thrombi, and for both the low and the high shear
rate cases. It is likely that thrombin plays an important role
by both directly stimulating platelet activation and by
structurally stabilizing the growing thrombus by catalyz-
ing fibrin formation.
The enzymatic inactivation of thrombin by antithrom-
bin III, in the absence of heparin, as would be found in the
Thrombin with AT III and Heparin
0o pm Thrombus
-10 0 10 20 30 40 50
Aw4ml Dm%aLA4. .._AAUa .lWA.uonf, PR
FIGURE 5 Local concentration profiles for thrombin produced by the
platelets of a 1O-Am thrombus with bulk phase inactivation by antithrom-
bin III accelerated by heparin. Wall shear rates are (a) 100 s-', (b) 500
s ',and (c) 1,500 s
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unaltered physiological case, was seen to have little effect
on the local thrombin concentrations that develop in the
vicinity of the thrombi.
In the altered physiological case, however, when the AT
III accelerator heparin has been introduced, very signifi-
cant inhibition of local thrombin activity was seen. This
case is shown in Fig. 5. Concentrations that develop are
_ 1.5 units/ml for the 10-,gm-long thrombus. Variation of
the wall shear rate was seen to have very little effect on the
concentration profiles, because of the rapid inactivation
near the surface. Variation of the size of the thrombus
from 10 to 20,m resulted in a fivefold increase in the
active thrombin concentration.
Although the addition of heparin to the system resulted
in great inactivation of thrombin, it is likely that these
reduced concentrations are still large enough to stimulate
platelet activation. In addition, thrombus stabilization by
fibrin formation would almost surely still be significant.
The assumption was made in this mathematical analysis
that the thrombin concentrations were small relative to
that of AT III. Hence, the diffusion of AT III was not
considered. This assumption was valid, since the largest
thrombin concentration, 42 units/ml or 0.38 ,uM, is still
one order of magnitude less than the AT III concentration,
4,uM.
Likewise, the assumption that prothrombin was also
present in sufficient excess was also reasonable. Prothrom-
bin is present in plasma at levels of approximately 1.0 ,uM,
about three times the largest thrombin concentration cal-
culated.
Comments
It should be kept in mind when interpreting these results
that some platelet stimulating agents act synergistically,
that is, that subthreshold levels of one agent present with
subthreshold levels of another agent can cause platelet
activation. Thus, for example, TxA2 generation may be
more important than it seems at first glance, for it may
potentiate the ability of platelets to respond with greater
sensitivity to some of the other aggregatory agents.
The transport model calculations suggest that the "ac-
tive cloud" of platelet active substances surrounding a
growing thrombus can provide a mechanism to explain the
elongated morphology and distal growth seen in model
vessels in contact with flowing whole blood (3). Thrombin
appears to be of profound importance, with a lesser but
perhaps still significant role for TxA2 and ADP.
This model does not account for flow disturbances
caused by the thrombus; the thrombus was considered to
be flush with the wall of the flow channel. This is reason-
able for small thrombi. Regions of recirculation might exist
immediately downstream from larger thrombi if flow
disturbances were accounted for. If this were to be the case,
then even higher concentrations of the platelet active
species might be present near the distal side of the throm-
bus.
This paper considers only the local contribution of the
generation and release of these platelet active substances to
the activation of platelets flowing near the surface and
their subsequent recruitment to the growing thrombus. It
does not attempt to assess the macroscopic effect of release
from many of these thrombi lumped together, which has
been addressed elsewhere (12). The local consideration
attempts to understand why platelets add onto a growing
thrombus at its distal end, whereas the macroscopic consid-
eration attempts to access the role of upstream release on
downstream thrombosis.
The behavior of blood platelets at a blood-material
interface depends largely on the nature of the material,
that is, on the stimulation of the platelets induced by
contact with the material. In the case of the contact of
blood with subendothelium, large mural thrombi form.
One might expect similar behavior on atheromatous
plaques. Mural thrombogenesis on an artificial polymeric
material depends on the type of polymer and method of
processing.
The computations contained herein are for the contact
of blood with collagenous surfaces, e.g., model subendothe-
lium. The rates of granule release and thromboxane A2
generation were taken from the literature were collagen
was used as the stimulatory agent. The results show that
for this material the release of granule bound ADP may be
marginally important in mural thrombogenesis. TxA2 gen-
eration may be important in mural thrombgenesis, particu-
larly in the propagation of larger thrombi. The synthesis of
thrombin on the surface of the platelet is probably very
important, and thrombin is significantly inactivated by the
addition of heparin. However, sizable concentrations of
thrombin still exist in the vicinity of the thrombus even
when heparin is used.
In the case of synthetic polymeric surfaces, such as those
used in artificial organs or blood-contacting devices, exper-
iments must be performed to determine the rates of release
and generation of these platelet active substances before
this analysis can be quantitatively applied to estimate these
concentrations near growing thrombi.
APPENDIX I
Flux Computations
The fluxes of the platelet active substances were estimated from a
knowledge of the generation rate per platelet and the number of platelets
in the model thrombus or the rate of growth of the thrombus. The details
of the flux computations are shown below for the 10-ym-long thrombus
case. Assumptions made give maximum wall fluxes of each compound.
Therefore the fluid concentrations represent an upper bound on those
obtained experimentally.
ADP Flux
The ADP flux was estimated assuming that 75% of the dense granule
contents are released immediately upon platelet attachment to the
growing thrombus (11). This value is typical for platelet stimulation by
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collagen. A single platelet contains 3.0 . 10-'7 moles of dense granule
bound ADP (11). Assuming a growth rate of 0.2 platelets/s (from our
experimental data on collagen [12, 17, 18]) over a thrombus area of 100
,Am', one may calculate the flux as
(0.2 plt/s)(3.0 - 10-'7 mol/plt)(0.75)
FIUXADP = 100oAm2
= 4.5 * 10-20 mol/Mm2 per s.
Thromboxane A2 Flux
Thromboxane A2 is generated enzymatically intracellularly near the
membrane of the platelet. In reference 19 thromboxane B2 generation
rates were measured for platelets stimulated by collagen in platelet-rich
plasma. Since TxA2 is rapidly converted into TxB2, this data may be
taken as a measure of TxA2 generation. Fig. 3 a of this reference shows
the production of 110 ng/ml of TxB2 during the 75-s-long ascending
phase of the aggregation stimulated by 15 g/ml collagen. Platelets were
present at 440,00/0ul, so the generation rate was approximately 4* 10-18
ng/plt per s or 1.1 10-I mol/plt per s. Assuming that the thrombus
consists of 20 platelets and has an area of 100Im2, one may calculate the
flux as
Flux = (20 plt)(1.1 1020 mo1/pIt/S)
FUTxA2 1I00 Mm2
= 2.3 * 10-21 mol/MAm2 per s
Thrombin Flux
Thrombin is generated enzymatically on the extracellular side of the
platelet membrane where factor Va, factor Xa, platelet phospholipid, and
Ca 2+ combine to form the prothrombinase complex. This complex
converts plasma prothrombin to thrombin. In reference 20, thrombin
generation rates were measured in the presence of platelets and physio-
logic concentrations of prothrombin. Under rate saturating concentra-
tions of factor Xa, which were less than physiologic, the thrombin
generation rate was 4.6 units/ml per min for a reaction mixture contain-
ing 1 * 108 platelets/ml. This is equivalent to 7.7 * 10` units/platelet
per s. Again assuming that the thrombus consists of 20 platelets and has
an area of 100 gim 2, the flux may be calculated as
(20 plt)(7.7 - 10-1' units/plt/s)FIUXThrombin = 100 ,m2
= 1.5 * 10-'° units/MAm2 per s
APPENDIX II
Reaction Rate Constant Computations
The details of the computation of the pseudo first order reaction rate
constants for the three bulk-phase inactivation reactions are given below.
Hydrolysis Of Thromboxane A2
Thromboxane A2 is hydrolyzed nonenzymatically in aqueous solution to
thromboxane B2, which is biologically inactive. The half life of this first
order reaction is 43 s (6). The reaction rate constant may be calculated as
kT,.A2 =-[ln(1/2)]/43 s) = 0.0161 s -'.
Inactivation Of Thrombin By AT III
Thrombin is inactivated by antithrombin III, which was assumed to
be present in the plasma at a concentration of 4.0 gM. The second
order reaction rate constant was taken directly from reference 24 as
k" = 4.25 * IO' M -' min ', where the form of reaction rate equation was
- d[ T]/dt = k" [AT] [T], where [T] is thrombin concentration and [AT]
is antithrombin III concentration. A pseudo first order reaction rate
constant may be calculated by assuming an antithrombin III concentra-
tion, which was chosen as 4 gM. One obtains a value for kth,ATTIII of 0.0283
s-'.
Inactivation Of Thrombin By AT III With
Heparin
The inactivation of thrombin by AT III is greatly accelerated by the
anticoagulant heparin. Heparin concentration was assumed to be equimo-
lar with AT III,4.0MgM or -2.0,g/ml. Table II in reference 25 gives the
second order reaction rate constant as a function of heparin concentration.
The data presented in reference 25 was for heparin concentrations much
lower than 2.0,g/ml. The data were extrapolated to obtain an estimate of
4.0 . 109 M -' min-'. The pseudo first order reaction rate constant may
be calculated, using the AT III concentation, as kfth.AT IIIhp = 267 s -'.
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